AB SCIENCE |
Market Closed -
Other stock markets
|
After market 11:00:34 pm | |||
| 1.96 EUR | +1.24% |
|
1.961 | +0.05% |
| 04/04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
| 03/04 | AB Science: reconsideration possible for masitinib in ALS | CF |
Chart calendar AB Science
3f6dbe908e0b46a198.cQjkPj9ozKKI3TgHPEePhFTCNsd-WXeMw0DyzhcNrGs.QVehWmwQvM2w7nBXSHPk_Xmsf6ZJACTAjijLu1JqxRsFf5FpTluk6eucSw~c14f4da128cb26f57f94ab4d27131e72
Upcoming events on AB Science
Past events on AB Science
| 04/03/2024 11:00 pm | Business Update Call |
| 30/11/2023 07:30 pm | Business Update Call |
| 29/09/2023 11:19 pm | Q2 2023 Earnings Release |
| 30/06/2023 07:00 pm | Annual General Meeting |
| 16/05/2023 | ALS Drug Development Summit |
| 28/04/2023 10:11 pm | Q4 2022 Earnings Release |
| 16/03/2023 10:30 pm | AB8939 Phase 1/2 Study Results Call |
| 30/09/2022 10:09 pm | Interim 2022 Earnings Release |
| 24/05/2022 | ALS Drug Development Summit |
| 29/04/2022 10:03 pm | FY 2021 Earnings Release |
| 28/02/2022 10:30 pm | Business Update Call |
| 07/12/2021 | International Symposium on ALS/MND |
| 30/09/2021 10:51 pm | Interim 2021 Earnings Release |
| 12/09/2021 | American Urological Association Meeting - Study AB12003 |
| 29/07/2021 07:30 pm | Alzheimers Association International Conference |
| 30/06/2021 | Shareholders Meeting |
| 04/06/2021 06:30 pm | American Society of Clinical Oncology Conference |
| 03/06/2021 10:00 pm | Masitinib Clinical Study Suspension Call |
| 25/05/2021 10:00 pm | Investor Meeting - Key Opinion Leader |
| 30/04/2021 10:15 pm | FY 2020 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1,70 | 1,57 1,55 1.65% | 1,58 | 0,00 | 0,93 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | -19,1 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | -17,5 -21,4 18.17% | 0,00 | 0,00 | -16,0 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
Net income Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | -13,6 | -19,6 |
|
EPS EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | -0,29 | -0,38 |
| Announcement Date | 30/04/19 | 30/04/20 | 30/04/21 | 01/03/23 | - |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 |
|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,79 0,70 13% | 0,78 0,80 -2.5% | 0,81 0,90 -10.33% |
|
EBIT Million EUR | Released Forecast Spread | -10,6 -14,6 27.54% | -6,90 -10,8 36% | |
| Announcement Date | 30/09/19 | 30/04/20 | 30/09/20 |
More events
Past sector events for AB Science
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AB Stock
- Calendar AB Science
